Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin

被引:0
|
作者
机构
来源
关键词
D O I
10.1089/genedge.5.1.152
中图分类号
学科分类号
摘要
引用
收藏
页码:800 / 807
相关论文
共 50 条
  • [1] Activist Investor Reported to Take $1 Billion Stake in BioMarin
    Philippidis, Alex
    [J]. HUMAN GENE THERAPY, 2023, 34 (23-24) : 1173 - 1177
  • [2] Gene Therapy Strategies for Usher Syndrome Type 1B
    Williams, David S.
    Lopes, Vanda S.
    [J]. RETINAL DEGENERATIVE DISEASES, 2012, 723 : 235 - 242
  • [3] BP reaps $1b profit from sale of PetroChina stake
    不详
    [J]. TCE, 2004, (752): : 13 - 13
  • [4] Lentiviral vectors as gene therapy vehicles of Usher syndrome 1B
    Yang, XJ
    Hashimoto, T
    Zhang, XM
    Azarian, SM
    Lillo, C
    Gibbs, D
    Williams, DS
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [5] Eli Lilly Establishes Gene Therapy Program with $1B Purchase of Prevail
    Philippidis, Alex
    [J]. HUMAN GENE THERAPY, 2021, 32 (1-2) : 10 - 13
  • [6] POLYMORPHISMS IN THE SEROTONIN 1B RECEPTOR GENE ARE ASSOCIATED WITH SELF-REPORTED EJACULATION LATENCY TIME
    Jern, P.
    Westberg, L.
    Johansson, A.
    Gunst, A.
    Eriksson, E.
    Sandnabba, N. K.
    Santtila, P.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 398 - 399
  • [7] Fatigue in RRMS in therapy with IFN β-1b
    Kotterba, S.
    Schaefer, C.
    Schoelzel, W.
    [J]. NERVENARZT, 2010, 81 : 37 - 38
  • [8] Assessment of Different Virus-Mediated Approaches for Retinal Gene Therapy of Usher 1B
    Lopes, Vanda S.
    Diemer, Tanja
    Williams, David S.
    [J]. RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 725 - 731
  • [9] Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B
    Hashimoto, T.
    Gibbs, D.
    Lillo, C.
    Azarian, S. M.
    Legacki, E.
    Zhang, X-M
    Yang, X-J
    Williams, D. S.
    [J]. GENE THERAPY, 2007, 14 (07) : 584 - 594
  • [10] Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B
    T Hashimoto
    D Gibbs
    C Lillo
    S M Azarian
    E Legacki
    X-M Zhang
    X-J Yang
    D S Williams
    [J]. Gene Therapy, 2007, 14 : 584 - 594